This is a notice of intent for a sole-source procurement with Roche for Ventana BenchMark ULTRA reagents, consumables, and service. The contract period is one year, from September 1, 2026, through August 31, 2027. It supports immunohistochemistry (IHC) and in-situ hybridization (ISH) testing for the Hematology Bone Marrow Pathology and Consultation Service. The acquisition will follow FAR Part 13 simplified acquisition procedures as a single-source purchase, with no solicitation document or request for quotations issued. Interested parties may submit comments to the contract specialist, but no competitive solicitation is planned.